[#item_full_content] BEI Participants Publicly Discuss “Bypassing” FDA Pathway as Federal Court Weighs Legality of CMS Cannabinoid Program On-Camera Statements From CMS Cannabinoid Program Participants Raise New Questions About Scientific Standards, Commercialization …
Read More